We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ABOS

Price
0.90
Stock movement down
-0.08 (-8.08%)
Company name
Acumen Pharmaceuticals Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
54.12M
Ent value
70.71M
Price/Sales
186.62
Price/Book
0.25
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-74.26%
3 year return
-37.56%
5 year return
-
10 year return
-
Last updated: 2025-04-18

DIVIDENDS

ABOS does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales186.62
Price to Book0.25
EV to Sales243.82

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count60.08M
EPS (TTM)-1.36
FCF per share (TTM)-1.12

Income statement

Loading...
Income statement data
Revenue (TTM)290.00K
Gross profit (TTM)162.00K
Operating income (TTM)-92.91M
Net income (TTM)-81.67M
EPS (TTM)-1.36
EPS (1y forward)-1.53

Margins

Loading...
Margins data
Gross margin (TTM)55.86%
Operating margin (TTM)-32036.55%
Profit margin (TTM)-28162.76%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash33.18M
Net receivables0.00
Total current assets207.63M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets266.98M
Accounts payable2.34M
Short/Current long term debt29.99M
Total current liabilities19.91M
Total liabilities49.77M
Shareholder's equity217.20M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-67.31M
Capital expenditures (TTM)30.00K
Free cash flow (TTM)-67.34M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-37.60%
Return on Assets-30.59%
Return on Invested Capital-37.58%
Cash Return on Invested Capital-30.99%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.98
Daily high1.00
Daily low0.87
Daily Volume487K
All-time high20.28
1y analyst estimate10.80
Beta0.04
EPS (TTM)-1.36
Dividend per share-
Ex-div date-
Next earnings date12 May 2025

Downside potential

Loading...
Downside potential data
ABOSS&P500
Current price drop from All-time high-95.56%-14.12%
Highest price drop-95.56%-56.47%
Date of highest drop17 Apr 20259 Mar 2009
Avg drop from high-73.29%-11.07%
Avg time to new high954 days12 days
Max time to new high953 days1805 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ABOS (Acumen Pharmaceuticals Inc) company logo
Marketcap
54.12M
Marketcap category
Small-cap
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2 that completed Phase I clinical trial to target soluble amyloid-beta oligomers. The company has a license agreement with Lonza Sales AG to manufacture and commercialize sabirnetug; and a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Employees
51
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...